Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
42.22
+1.57 (3.86%)
Nov 21, 2024, 12:41 PM EST - Market open
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $2.51 billion as of November 21, 2024. Its market cap has increased by 164.24% in one year.
Market Cap
2.51B
Enterprise Value
1.85B
1-Year Change
164.24%
Ranking
Category
Stock Price
$42.12
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $2.51B, an increase of 1,363.71%. That is a compound annual growth rate of 38.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.42B | 83.18% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Catalyst Pharmaceuticals | 2.48B |
| Zai Lab | 2.48B |
| Scholar Rock Holding | 2.47B |
| Twist Bioscience | 2.46B |
| Ardent Health Partners | 2.43B |
| iRhythm Technologies | 2.41B |
| Arrowhead Pharmaceuticals | 2.36B |
| Longboard Pharmaceuticals | 2.33B |